Physician profile
Jeffrey Schock
NPI 1710941273
$12,258.83
in general payments reported to CMS, 2019-2025
57 companies · $2,052 in 2025
The $2,052 reported for 2025 was more than what 80% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,996 · 2020: $933 · 2021: $1,147 · 2022: $1,765 · 2023: $2,498 · 2024: $1,867 · 2025: $2,052.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,308 · Education: $109.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,308.38 |
| Education | $108.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,229.39 | 2021-2025 | Interstim |
| Antares Pharma, INC. | $938.94 | 2019-2025 | Xyosted, Tlando, Nocdurna |
| Astellas Pharma US INC | $885.77 | 2019-2025 | Myrbetriq, Xtandi |
| Sumitomo Pharma America, INC. | $821.22 | 2023-2025 | Gemtesa, Orgovyx |
| Ferring Pharmaceuticals INC. | $610.26 | 2019 | |
| Coloplast Corp | $552.00 | 2019-2025 | Porges Coloplast, Speedicath |
| Axonics, INC. | $548.32 | 2020-2024 | Axonics |
| Boston Scientific Corporation | $533.74 | 2019-2025 | Ams 700, Rezum Generator, Lithovue |
| Teleflex LLC | $512.80 | 2021-2023 | Urolift |
| Myriad Genetic Laboratories, INC. | $396.70 | 2021-2024 | Prolaris |
| Tolmar, INC. | $344.32 | 2023-2025 | Jatenzo, Eligard |
| Urovant Sciences INC | $336.75 | 2021-2022 | |
| Olympus America INC. | $321.69 | 2019-2025 | Itind System |
| Urogen Pharma, INC. | $304.31 | 2021-2025 | Jelmyto |
| Pfizer INC. | $295.14 | 2019-2025 |
Show all 57 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Schock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.